This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Zheng, W. Articles by Holtzman, J. L. Search for Related Content PubMed PubMed Citation Articles by Zheng, W. Articles by Holtzman, J. L.

Epidemiological Study of Urinary 6ß-Hydroxycortisol to Cortisol Ratios and Breast Cancer Risk¹

Vanderbilt Center for Health Services Research and Vanderbilt-Ingram Cancer Center, Vanderbilt University, Nashville, Tennessee 37232-8300 [W. Z., X-O. S., Q. D., W-Q. W.]; Department of Epidemiology, Shanghai Cancer Institute, Shanghai, China 200032 [F. J., Q. D., Y-T. G.]; Veterans Affairs Medical Center, Minneapolis, Minnesota 55417 [L. A. D., J. L. H.]; and Department of Pharmacology, University of Minnesota School of Medicine, Minneapolis, Minnesota 55454 [L. A. D., J. L. H.]

The ratio of urinary 6ß-hydroxycortisol:cortisol is a measure of the activity of cytochrome p450 3A4 (CYP3A4). CYP3A4 catalyzes the formation of the genotoxic estrogen, 16-hydroxyestrone. It is also involved in the activation of many other mammary carcinogens, such as the polycyclic aromatic hydrocarbons and heterocyclic amines. We evaluated the association between urinary cortisol ratios and breast cancer risk in a subgroup of women who participated in a population-based case-control study in Shanghai. Overnight urine samples from 246 case-control pairs were assayed for 6ß-hydroxycortisol (6ß-OHC) to cortisol. The urine samples from all of the breast cancer patients were collected before any chemotherapy or radiotherapy. In-person interviews were conducted to obtain comprehensive information on dietary habits, reproductive history, and other lifestyle factors. The median levels of 6ß-OHC:cortisol ratios were 2.61 in cases and 2.16 in controls, a 20.8% difference (P < 0.001). The case-control difference was larger in women over 45 years of age (31.3% difference; P < 0.001) than younger women (6.0%; P = 0.45). After adjusting for confounding variables, the risks of breast cancer were increased from 1.0 (reference) to 1.6 [95% confidence interval (CI), 0.9–3.1], 2.2 (95% CI, 1.1–4.2), and 3.7 (95% CI, 1.9–7.4; P for trend, <0.001) with increasing levels of 6ß-OHC:cortisol ratios. The positive association was more pronounced among older women (>45 years) than among younger women (45 years). The adjusted odds ratios associated with the highest cortisol ratio were 6.0 (95%CI, 2.2–16.1) among older women and 2.2 (95%CI, 0.8–6.1) among younger women. The association of the 6ß-OHC:cortisol ratio was stronger among older women who had a high body mass index, late age at menopause, and early age at menarche (factors related to high endogenous estrogen exposure) than those who did not have these factors. These findings are consistent with the role of CYP3A4 in estrogen and carcinogen metabolism and suggest that high CYP3A4 activity may be a risk factor for breast cancer risk.

This article has been cited by other articles:

				W. Zheng, W.-H. Chow, G. Yang, F. Jin, N. Rothman, A. Blair, H.-L. Li, W. Wen, B.-T. Ji, Q. Li, et al. The Shanghai Women's Health Study: Rationale, Study Design, and Baseline Characteristics Am. J. Epidemiol., December 1, 2005; 162(11): 1123 - 1131. [Abstract] [Full Text] [PDF]

				A.-M. Yu, K. Fukamachi, K. W. Krausz, C. Cheung, and F. J. Gonzalez Potential Role for Human Cytochrome P450 3A4 in Estradiol Homeostasis Endocrinology, July 1, 2005; 146(7): 2911 - 2919. [Abstract] [Full Text] [PDF]

				M. J. Ronis, Y. Chen, C.-H. Jo, P. Simpson, and T. M. Badger Diets Containing Soy Protein Isolate Increase Hepatic CYP3A Expression and Inducibility in Weanling Male Rats Exposed during Early Development J. Nutr., December 1, 2004; 134(12): 3270 - 3276. [Abstract] [Full Text] [PDF]

				C. Keshava, E. C. McCanlies, and A. Weston CYP3A4 Polymorphisms--Potential Risk Factors for Breast and Prostate Cancer: A HuGE Review Am. J. Epidemiol., November 1, 2004; 160(9): 825 - 841. [Abstract] [Full Text] [PDF]

				T. Furuta, A. Suzuki, C. Mori, H. Shibasaki, A. Yokokawa, and Y. Kasuya EVIDENCE FOR THE VALIDITY OF CORTISOL 6{beta}-HYDROXYLATION CLEARANCE AS A NEW INDEX FOR IN VIVO CYTOCHROME P450 3A PHENOTYPING IN HUMANS Drug Metab. Dispos., November 1, 2003; 31(11): 1283 - 1287. [Abstract] [Full Text] [PDF]

				H. Jernstrom, T.L. Klug, D.W. Sepkovic, H.L. Bradlow, and S.A. Narod Predictors of the plasma ratio of 2-hydroxyestrone to 16{alpha}-hydroxyestrone among pre-menopausal, nulliparous women from four ethnic groups Carcinogenesis, May 1, 2003; 24(5): 991 - 1005. [Abstract] [Full Text] [PDF]

				S. Davis, D. Mirick, and R. Stevens RESPONSE: Re: Night Shift Work, Light at Night, and Risk of Breast Cancer J Natl Cancer Inst, April 3, 2002; 94(7): 533 - 533. [Full Text] [PDF]